Finance

Lists
AQST:NASDAQ
Aquestive Therapeutics Inc
US$ ४.६७
-१.६८%
(-०.०८०) 1D
US$ ४.५९
-१.७१% (-०.०८०)
After hours
Closed: सेप्टेम्बर २९, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AQST...
Open
US$ ४.७०
High
US$ ४.७५
Low
US$ ४.५५
Mkt. cap
५८.६१ करोड
Avg. vol.
२७.८३ लाख
Volume
१७.०१ लाख
52-wk high
US$ ७.५५
52-wk low
US$ २.९३
EPS
-US$ ०.६५
Beta
१.४८
Shares outstanding
१२.५५ करोड
No. of employees
१४७
Open
US$ ४.७०
High
US$ ४.७५
Low
US$ ४.५५
Mkt. cap
५८.६१ करोड
Avg. vol.
२७.८३ लाख
Volume
१७.०१ लाख
52-wk high
US$ ७.५५
52-wk low
US$ २.९३
EPS
-US$ ०.६५
Beta
१.४८
Shares outstanding
१२.५५ करोड
No. of employees
१४७
News stories
From web sources and news partners
TipRanks
TipRanks
·
८ घण्टा पहिले
Aquestive Therapeutics Adds Veteran Executive to Board
Investing.com Canada
Investing.com Canada
·
८ घण्टा पहिले
Aquestive appoints Rich Daly to board of directors By Investing.com
Investing.com Canada
Investing.com Canada
·
८ घण्टा पहिले
Form 8K Aquestive Therapeutics Inc For: 29 September By Investing.com
About Aquestive Therapeutics Inc
CEO-
Employees१४७
Founded२००४
HeadquartersWarren, न्यु जर्सी, संयुक्त राज्य अमेरिका
Sector-
Websiteaquestive.com
Analyst ratings
Based on 3 analysts giving stock ratings to AQST in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AQST in the last 3 months.
Highest
Current US$ ४.६७
US$ १०.०० (+११४.१३%)
Average
US$ ८.६७ (+८५.६५%)
Lowest
US$ ६.०० (+२८.४८%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Maintained
US$ १०.००
+११४.१%
09/21/2026
Francois Brisebois
LifeSci Capital
Buy
Reiterated
US$ १०.००
+११४.१%
09/17/2026
Thomas Flaten
Lake Street
Buy
Maintained
US$ ६.००
+२८.५%
09/17/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
US$ ११.००
+१३५.५%
06/25/2026
Andreas Argyrides
Chardan Capital
Buy
Reiterated
US$ ८.००
+७१.३%
06/25/2026
Roanna Ruiz
Leerink Partners
Buy
Reiterated
US$ ९.००
+९२.७%
05/15/2026
David Amsellem
Piper Sandler
Buy
Reiterated
US$ ८.००
+७१.३%
05/15/2026
James Molloy
Alliance Global Partners
Buy
Maintained
US$ ९.००
+९२.७%
05/14/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.२८ करोड
१.३० करोड
१.४४ करोड
१.३८ करोड
Cost of goods sold
४५.०६ लाख
५८.३६ लाख
३४.६९ लाख
४०.१७ लाख
Cost of revenue
४५.०६ लाख
५८.३६ लाख
३४.६९ लाख
४०.१७ लाख
Research and development expenses
४५.३० लाख
३१.९६ लाख
४२.०४ लाख
३९.६२ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.५२ करोड
३.२८ करोड
१.१० करोड
१.४१ करोड
Operating expense
१.९८ करोड
३.६० करोड
१.५२ करोड
१.८० करोड
Total operating expenses
२.४३ करोड
४.१९ करोड
१.८६ करोड
२.२० करोड
Operating income
-१.१५ करोड
-२.८८ करोड
-४२.०४ लाख
-८२.२३ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-१.५४ करोड
-३.१९ करोड
-८०.५७ लाख
-२.२९ करोड
EBT excluding unusual items
-१.५४ करोड
-३.१९ करोड
-८०.५७ लाख
-१.१२ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-१.५४ करोड
-३.१९ करोड
-८०.५७ लाख
-२.२९ करोड
Net profit margin
-१२०.६१%
-२४४.७९%
-५५.७७%
-१६५.४५%
Earnings per share
-०.११
-०.१४
-०.०५
-०.०७
Interest and investment income
३.०६ लाख
१२.५२ लाख
८३.०० हजार
८.८२ लाख
Interest expense
-४२.७३ लाख
-४२.७३ लाख
-३९.३६ लाख
-३८.४० लाख
Net interest expenses
-३९.६७ लाख
-३०.२१ लाख
-३८.५३ लाख
-२९.५८ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.१३ करोड
-२.८७ करोड
-४०.९१ लाख
-८०.८७ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू